About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04172077

Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes

This project will assess self-efficacy levels(SE) ,resiliency and attachment style of adolescent with type 1 diabetes and their caregivers.SE and attachment style of patients and parents will be compa...

Lead sponsor: The Hospital for Sick Children•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

The Hospital for Sick Children

Age

12 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•T1DM patients age 12 - 18 yrs from Sick Kids Diabetes Clinic and a primary caregiver
•T1DM \> 1yr and able to communicate in English

Exclusion Criteria

•Families who cannot communicate in English (read, write, speak)
•Diagnosed less than 1 year diabetes
•Transient form of Diabetes (such as medication induced diabetes)
•Exclude type 2 Diabetes and CFRD (cystic fibrosis related diabetes)

Related studies

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

NCT07139808 · Type1diabetes

Genetics Of Autoimmunity In Type I Diabetes

NCT03648918 · Type1diabetes, Diabetes Mellitus, Type 1, and more

Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference

NCT06646107 · Type1diabetes

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

NCT05054361 · Type1diabetes

RECRUITINGPhase 1

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

NCT06753994 · Diabetes, Type1diabetes, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 8, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment170

Start dateSep 2019

Last updatedJul 8, 2021

Condition

Locations shown

The Hospital for Sick Children

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions